PMID- 28831699
OWN - NLM
STAT- MEDLINE
DCOM- 20180924
LR  - 20181113
IS  - 1573-2630 (Electronic)
IS  - 0165-5701 (Linking)
VI  - 38
IP  - 5
DP  - 2018 Oct
TI  - Comparison of cumulative dissipated energy delivered by active-fluidic pressure 
      control phacoemulsification system versus gravity-fluidics.
PG  - 1907-1913
LID - 10.1007/s10792-017-0674-4 [doi]
AB  - PURPOSE: To compare the cumulative dissipated energy (CDE), aspiration time and 
      estimated aspiration fluid utilized during phacoemulsification cataract surgery 
      using two phacoemulsification systems . METHODS: A total of 164 consecutive eyes 
      of 164 patients undergoing cataract surgery, 82 in the active-fluidics group and 
      82 in the gravity-fluidics group were enrolled in this study. Cataracts graded 
      NII to NIII using LOCS II were included. Each subject was randomly assigned to 
      one of the two platforms with a specific configuration: the active-fluidics 
      Centurion ((R)) phacoemulsification system or the gravity-fluidics Infiniti ((R)) 
      Vision System. CDE, aspiration time (AT) and the mean estimated aspiration fluid 
      (EAF) were registered and compared. RESULTS: A mean age of 68.3 +/- 9.8 years was 
      found (range 57-92 years), and no significant difference was evident between both 
      groups. A positive correlation between the CDE values obtained by both platforms 
      was verified (r = 0.271, R (2) = 0.073, P = 0.013). Similarly, a significant 
      correlation was evidenced for the EAF (r = 0.334, R (2) = 0.112, P = 0.046) and 
      AT values (r = 0.156, R (2) = 0.024, P = 0.161). A statistically significantly 
      lower CDE count, aspiration time and estimated fluid were obtained using the 
      active-fluidics configuration when compared to the gravity-fluidics configuration 
      by 19.29, 12.10 and 9.29%, respectively (P = 0.001, P < 0.0001 and P = 0.001). 
      CONCLUSIONS: The active-fluidics Centurion ((R)) phacoemulsification system 
      achieved higher surgical efficiency than the gravity-fluidics Infiniti ((R)) IP 
      system for NII and NIII cataracts.
FAU - Gonzalez-Salinas, Roberto
AU  - Gonzalez-Salinas R
AUID- ORCID: 0000-0001-6654-5191
AD  - Research Department, Hospital Luis Sanchez Bulnes, Asociacion para Evitar la 
      Ceguera en Mexico I.A.P., Vicente Garcia Torres 46, Barrio San Lucas, Coyoacan, 
      04030, Mexico City, Mexico. dr.gonzalezsalinas@gmail.com.
FAU - Garza-Leon, Manuel
AU  - Garza-Leon M
AD  - Direccion de Ciencias Medicas de la Division de Ciencias de la Salud, Universidad 
      de Monterrey, Monterrey, Nuevo Leon, Mexico.
FAU - Saenz-de-Viteri, Manuel
AU  - Saenz-de-Viteri M
AD  - Department of Ophthalmology, Universidad de Navarra, Pamplona, Spain.
FAU - Solis-S, Juan C
AU  - Solis-S JC
AD  - Biomedical Research Department, Universidad Autonoma de Queretaro, 76170, 
      Queretaro, Mexico.
FAU - Gulias-Canizo, Rosario
AU  - Gulias-Canizo R
AD  - Research Department, Hospital Luis Sanchez Bulnes, Asociacion para Evitar la 
      Ceguera en Mexico I.A.P., Vicente Garcia Torres 46, Barrio San Lucas, Coyoacan, 
      04030, Mexico City, Mexico.
AD  - Centro de Investigacion y Estudios Avanzados, I.P.N. (CINVESTAV), 07360, Mexico 
      City, Mexico.
FAU - Quiroz-Mercado, Hugo
AU  - Quiroz-Mercado H
AD  - University of Colorado, Denver, CO, USA.
LA  - eng
PT  - Comparative Study
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20170822
PL  - Netherlands
TA  - Int Ophthalmol
JT  - International ophthalmology
JID - 7904294
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Equipment Design
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Phacoemulsification/*instrumentation
MH  - Postoperative Complications/*prevention & control
MH  - Pressure
MH  - Prospective Studies
MH  - Time Factors
MH  - Visual Acuity
OTO - NOTNLM
OT  - Active-fluidics
OT  - Cataract surgery
OT  - Cumulative dissipated energy
OT  - Gravity-fluidics
OT  - Phacoemulsification
EDAT- 2017/08/24 06:00
MHDA- 2018/09/25 06:00
CRDT- 2017/08/24 06:00
PHST- 2017/05/25 00:00 [received]
PHST- 2017/08/01 00:00 [accepted]
PHST- 2017/08/24 06:00 [pubmed]
PHST- 2018/09/25 06:00 [medline]
PHST- 2017/08/24 06:00 [entrez]
AID - 10.1007/s10792-017-0674-4 [pii]
AID - 10.1007/s10792-017-0674-4 [doi]
PST - ppublish
SO  - Int Ophthalmol. 2018 Oct;38(5):1907-1913. doi: 10.1007/s10792-017-0674-4. Epub 
      2017 Aug 22.